losartan has been researched along with Choroid Neovascularization in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan seems to inhibit development of laser-induced choroidal neovascularization." | 1.31 | Inhibitory effect of losartan on laser-induced choroidal neovascularization in rats. ( Hikichi, T; Horikawa, Y; Mori, F; Sasaki, M; Takamiya, A; Takeda, M; Yoshida, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hikichi, T | 1 |
| Mori, F | 1 |
| Takamiya, A | 1 |
| Sasaki, M | 1 |
| Horikawa, Y | 1 |
| Takeda, M | 1 |
| Yoshida, A | 1 |
1 other study available for losartan and Choroid Neovascularization
| Article | Year |
|---|---|
Inhibitory effect of losartan on laser-induced choroidal neovascularization in rats.
Topics: Angiotensin Receptor Antagonists; Animals; Choroid; Choroidal Neovascularization; Fluorescein Angiog | 2001 |